[Improvement of coronary prognosis by reducing LDL-cholesterol].
Elevated LDL-cholesterol levels mean increased risk for coronary heart disease. In different studies the indication for decreasing high LDL-cholesterol in patients with coronary heart disease was proven. This is also the case with patients suffering from high LDL-cholesterol but not yet coronary heart disease. It is supposed that with longer duration of studies the total mortality between verum and placebo groups will also reach significance.
Medizinischen Poliklinik der Universität München.
G
G
Wolfram
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D008078:Cholesterol, LDL / Q000097:blood*; D003324:Coronary Artery Disease / Q000097:blood / Q000517:prevention & control*; D006801:Humans; D008137:Longitudinal Studies; D012307:Risk Factors
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL
Verbesserung der Koronarprognose durch Senkung des LDL-Cholesterins.